Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study.

Autor: Greco S; Department of Translational Medicine and for Romagna, University of Ferrara, Via Luigi Borsari, 46, 46 - 44121, Ferrara, Ferrara, Italy.; Medical Department, Azienda Unità Sanitaria Locale di Ferrara, Delta Hospital, Via Valle Oppio, 2, 44023, Lagosanto, Ferrara, Italy., Salatiello A; Department of Computer Science, University of Tübingen, Geschwister-Scholl-Platz, 72074, Tübingen, Germany., De Motoli F; Local Health Unit of Ferrara, Medical Direction, Via Cassoli, 30, 44121, Ferrara, Italy., Giovine A; Medical Department, Azienda Unità Sanitaria Locale di Ferrara, Delta Hospital, Via Valle Oppio, 2, 44023, Lagosanto, Ferrara, Italy., Veronese M; Research and Innovation Unit, Azienda-Ospedaliero Universitaria di Ferrara, Via Aldo Moro, 8, 44124, Cona, Ferrara, Italy., Cupido MG; Long-term Care, Azienda Unità Sanitaria Locale di Ferrara, Delta Hospital, Via Valle Oppio, 2, 44023, Lagosanto, Ferrara, Italy., Pedarzani E; Research and Innovation Unit, Azienda-Ospedaliero Universitaria di Ferrara, Via Aldo Moro, 8, 44124, Cona, Ferrara, Italy., Valpiani G; Research and Innovation Unit, Azienda-Ospedaliero Universitaria di Ferrara, Via Aldo Moro, 8, 44124, Cona, Ferrara, Italy., Passaro A; Department of Translational Medicine and for Romagna, University of Ferrara, Via Luigi Borsari, 46, 46 - 44121, Ferrara, Ferrara, Italy. angelina.passaro@unife.it.; Medical Dapartment, Azienda-Ospedaliero Universitaria di Ferrara, Via Aldo Moro, 8, 44124, Cona, Ferrara, Italy. angelina.passaro@unife.it.

Publikováno v: Cardiovascular diabetology [Cardiovasc Diabetol] 2024 May 03; Vol. 23 (1), pp. 153. Date of Electronic Publication: 2024 May 03.

Human Papilloma Virus Vaccination: Focus on the Italian Situation.

Autor: Gabutti G; Pro-Tempore National Coordinator of the Work Group 'Immunizations and Vaccinal Policies' of the Italian Scientific Society of Hygiene, Preventive Medicine and Public Health (SItI), 16033 Lavagna, Italy., d'Anchera E; Post-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy., De Motoli F; Post-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy., Savio M; Post-Graduate School of Hygiene and Preventive Medicine, University of Ferrara, 44121 Ferrara, Italy., Stefanati A; Department of Medical Sciences, University of Ferrara, 44121 Ferrara, Italy.

Publikováno v: Vaccines [Vaccines (Basel)] 2021 Nov 23; Vol. 9 (12). Date of Electronic Publication: 2021 Nov 23.

Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies.

Autor: Giordano, Antonio^1,2 (AUTHOR) antonio.giordano@guest.policlinicogemelli.it, Quattrone, Martina¹ (AUTHOR) viscovomarcello@gmail.com, Viscovo, Marcello¹ (AUTHOR) barbara.fiori@policlinicogemelli.it, Fiori, Barbara¹ (AUTHOR) rosaria.santangelo@policlinicogemelli.it, Santangelo, Rosaria¹ (AUTHOR) maurizio.sanguinetti@unicatt.it, Sanguinetti, Maurizio^1,3 (AUTHOR) livio.pagano@unicatt.it, Pagano, Livio^1,4 (AUTHOR)

Publikováno v: Viruses (1999-4915). Oct2024, Vol. 16 Issue 10, p1520. 8p.

SARS-CoV-2 infection and H1N1 vaccination: does a relationship between the two factors really exist? A retrospective analysis of a territorial cohort in Ferrara, Italy.

Autor: Greco S; Department of Translational Medicine, University of Ferrara, Ferrara, Italy. psn@unife.it., Bella A, Bonsi B, Fabbri N, Califano A, Morrone S, Chessa P, Pistolesi C, Zuliani G, De Motoli F, Manfredini R, De Giorgi A, Passaro A

Publikováno v: European review for medical and pharmacological sciences [Eur Rev Med Pharmacol Sci] 2021 Mar; Vol. 25 (6), pp. 2795-2801.

Ceftolozane/Tazobactam and Ceftazidime/Avibactam for Multidrug-Resistant Gram-Negative Infections in Immunocompetent Patients: A Single-Center Retrospective Study.

Autor: Cultrera R; Infectious and Tropical Diseases, Department of Morphology, Surgery and Experimental Medicine, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., Libanore M; Infectious Diseases Unit, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., Barozzi A; Clinical Microbiology, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., d'Anchera E; Postgraduate School of Hygiene and Preventive Medicine, University of Ferrara, Via Fossato Di Mortara 64/B, 44121 Ferrara, Italy., Romanini L; Clinical Microbiology, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., Fabbian F; Clinica Medica Unit, Department of Medical Sciences, University of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., De Motoli F; Postgraduate School of Hygiene and Preventive Medicine, University of Ferrara, Via Fossato Di Mortara 64/B, 44121 Ferrara, Italy., Quarta B; Department of Pharmacy, University 'S. Anna' Hospital of Ferrara, Via Aldo Moro 8, 44124 Ferrara, Italy., Stefanati A; Public Health Medicine Section, Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy., Bolognesi N; Postgraduate School of Hygiene and Preventive Medicine, University of Ferrara, Via Fossato Di Mortara 64/B, 44121 Ferrara, Italy., Gabutti G; Public Health Medicine Section, Department of Medical Sciences, University of Ferrara, Via Fossato di Mortara 64/B, 44121 Ferrara, Italy.

Publikováno v: Antibiotics (Basel, Switzerland) [Antibiotics (Basel)] 2020 Sep 24; Vol. 9 (10). Date of Electronic Publication: 2020 Sep 24.